Presage Biosciences' Series C Round

Presage Biosciences raised a round of funding on August 20, 2015. Investors include Takeda Ventures.

Presage Biosciences is an oncology company that is pioneering an entirely novel approach to evaluating patient response to drugs in clinical trials. Using its patented CIVO technology, the company del…

Articles about Presage Biosciences' Series C Round: